Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys

Japanese Journal of Pharmacology

Volumn 77, Issue 3, 1998, Pages 227-233

  Domino, Edward F ^a   Ni, Lisong ^a   Zhang, Huilei ^a   Kohno, Yasuko ^b   Sasa, Masashi ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hemiparkinsonism (monkey); Dopamine D2 like receptor agonist; Functional improvement; MPTP; Talipexole

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; TALIPEXOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARM MOVEMENT; ARTICLE; CIRCLING BEHAVIOR; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HAND MOVEMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; MONKEY; NONHUMAN; PARKINSONISM; RATING SCALE; SEDATION;

EID: 0031665724     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.77.227     Document Type: Article

References (17)

1. 2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys. J Pharmacol Exp Ther 264, 221-225 (1993)
2. 2 receptors in MPTP-induced hemiparkinsonian monkeys. J Pharmacol Exp Ther 265, 1387-1391 (1993)
3. 2-Adrenoceptor subtypes: Selectivity of various agonists and relative distribution of receptors as determined in rats. Eur J Pharmacol 73, 313-321 (1981)
4. Pichler L and Kobinger W: Centrally mediated cardiovascular effects of B-HT 920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]azepin dihydrochloride) a hypotensive agent of the "clonidine type". J Cardiovasc Pharmacol 3, 269-277 (1981)
5. Anden NE, Golembiowska-Nikitin K and Thornström U: Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn Schmiedebergs Arch Pharmacol 321, 100-104 (1982)
6. Anden NE, Nilsson H, Ros E and Thornström U: Effects of B-HT 920 and B-HT 933 on dopamine and noradrenal autoreceptors in the rat brain. Acta Pharmacol Toxicol 52, 51-56 (1983)
7. Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C and Schingnitz G: The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: A novel approach to treatment. Eur J Pharmacol 131, 75-86 (1986)
8. Kohno Y, Sibata S, Ohno M and Watanabe S: Electroencephalographic study on sedative effects of talipexole, a novel antiparkinsonian drug, in rats with chronic electrode implants. Pharmacometrics 51, 45-52 (1996)
9. 3 receptor blocking properties of the antiparkinsonian agent, talipexole. Gen Pharmacol 27, 779-785 (1996)
10. Nakanisi T, Kowa H, Mizuno Y and Yanagisawa N: The clinical evaluation of B-HT 920 (talipexole hydrochloride) in Parkinson's disease. Clin Eval 21, 59-110 (1993)
11. Domino EF, Ni LS, Kohno Y and Sasa M: Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP induced hemiparkinsonian monkeys. Eur J Pharmacol 325, 137-144 (1997)
12. The Guide for the Care and Use of Laboratory Animals, Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council, pp 1-83, US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication #86-23, Superintendent of Documents, US Government Printing Office, Washington, DC, Revised (1985)
13. The B Virus Working Group: Guidelines for prevention of herpes virus simiae (B virus) infection in monkey handlers. J Med Primatol 17, 77-83 (1988)
14. Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM and Kopin IJ: Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39, 7-16 (1986)
15. Irifune M, Nomoto M and Fukuda T: Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets. Eur J Pharmacol 238, 235-240 (1993)
16. Irifune M, Nomoto M and Fukuda T: Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-DOPA and as chronic treatment. Eur J Pharmacol 264 117-123 (1994)
17. 2 receptor stimulation in cynomolgus monkeys with unilateral lesions in ventromedial tegmentum. Eur J Pharmacol 319, 197-205 (1997)